These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18374131)

  • 1. Long-term survival of HLA-DR15+ pig skin in SCID mice after reconstitution with human peripheral blood mononuclear cells and under short-term immunosuppression.
    Tai HC; Tu CF; Lee JM; Ho LL; Tseng YL; Chou NK; Yang TS; Weng CN; Lee PH; Chang KJ; Tang YB
    Transplant Proc; 2008 Mar; 40(2):570-3. PubMed ID: 18374131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
    Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
    Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
    Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
    Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z; Tibbles L; Yilmaz S; Gao Y; MacDonald A
    Transplant Proc; 2005 Jun; 37(5):2300-2. PubMed ID: 15964404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
    Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
    Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
    Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
    Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse.
    Pober JS; Bothwell AL; Lorber MI; McNiff JM; Schechner JS; Tellides G
    Springer Semin Immunopathol; 2003 Sep; 25(2):167-80. PubMed ID: 12955465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
    Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
    Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
    Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors.
    Bouwman LH; Ling Z; Duinkerken G; Pipeleers DG; Roep BO
    Hum Immunol; 2005 May; 66(5):494-500. PubMed ID: 15935886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells from presensitized donors fail to cause graft-versus-host disease in a pig-to-mouse xenotransplantation model.
    Eguchi H; Knosalla C; Lan P; Cheng J; Diouf B; Wang L; Abe M; Schuurman HJ; Sachs DH; Sykes M; Cooper DK; Yang YG
    Transplantation; 2004 Dec; 78(11):1609-17. PubMed ID: 15591949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice.
    Sun R; Zhang J; Zhang C; Zhang J; Liang S; Sun A; Wang J; Tian Z
    Cell Mol Immunol; 2004 Apr; 1(2):129-36. PubMed ID: 16212900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin graft of double transgenic pigs of N-acetylglucosaminyltransferase III (GnT-III) and DAF (CD55) genes survived in cynomolgus monkey for 31 days.
    Fujita T; Miyagawa S; Ezoe K; Saito T; Sato N; Takahagi Y; Murakami H; Matsunami K; Shirakura R; Taniguchi N
    Transpl Immunol; 2004 Dec; 13(4):259-64. PubMed ID: 15589738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the human anti-pig cellular immune response using the Hu-scid mouse-porcine skin graft model.
    Moss A; Fryer JP; Leventhal JR; Simone P; Chen S; Reinsmoen N; Matas AJ
    Transplant Proc; 1994 Jun; 26(3):1209. PubMed ID: 8029889
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
    Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
    Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of iloprost and various prostaglandin derivatives on mouse skin allograft survival, HLA-DR antigen expression and eicosanoid metabolism by human leukocytes.
    Becker K; Gruner S; Lueddeckens G; von Baehr R; Förster W
    Allerg Immunol (Leipz); 1990; 36(4):253-65. PubMed ID: 1711283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.